DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

Phase 1

Completed

Conditions: Relapsed Or Refractory Multiple Myeloma

Interventions: Drug: thymoglobulin

First Posted Date: 2007-10-17

Last Posted Date: 2013-04-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 6

Registration Number: NCT00545519

Locations: 🇺🇸
Washington Unvierstiy in St. Louis, St. Louis, Missouri, United States

Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Phase 2

Completed

Conditions: Hodgkin Disease

Interventions: Drug: Lenalidomide

First Posted Date: 2007-10-05

Last Posted Date: 2017-11-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 80

Registration Number: NCT00540007

Locations: 🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

and more 2 locations

Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement

Phase 2

Terminated

Conditions: Colorectal Cancer
Metastases

Interventions: Drug: Cetuximab
Drug: Bevacizumab
Drug: Leucovorin
Drug: Oxaliplatin
Drug: Fluorouracil

First Posted Date: 2007-10-01

Last Posted Date: 2016-12-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 9

Registration Number: NCT00537823

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules

Not Applicable

Completed

Conditions: Thyroid Neoplasms

Interventions: Other: FDG-PET Scan

First Posted Date: 2007-10-01

Last Posted Date: 2014-09-22

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 84

Registration Number: NCT00537797

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
🇺🇸
St. Louis University School of Medicine, St. Louis, Missouri, United States
🇺🇸
VAMC, St. Louis, Missouri, United States

Epoetin Alfa for HIV-Associated Neuropathy Trial

Phase 2

Withdrawn

Conditions: HIV Infections
Neuropathy

Interventions: Drug: epoetin alfa

First Posted Date: 2007-09-12

Last Posted Date: 2011-08-09

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT00528593

Glucose and Lipid Metabolism on Antipsychotic Medication

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus
Hyperglycemia
Schizoaffective Disorder
Schizophrenia

Interventions: Drug: risperidone
Drug: olanzapine
Drug: quetiapine
Drug: ziprasidone

First Posted Date: 2007-08-14

Last Posted Date: 2019-10-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 96

Registration Number: NCT00515723

Locations: 🇺🇸
Washington Univeristy School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Washington University School of Medicine, Psychiatry Dept., Saint Louis, Missouri, United States

Case Management and Environmental Control in Asthma

Phase 3

Completed

Conditions: Asthma

Interventions: Behavioral: Asthma coaching

First Posted Date: 2007-08-10

Last Posted Date: 2015-12-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 189

Registration Number: NCT00514436

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

The Natural History of Community-Associated MRSA Infections and Decolonization Strategies

Not Applicable

Completed

Conditions: Staphylococcal Skin Infections
Staphylococcus Aureus
Abscesses
Furunculosis

Interventions: Drug: Mupirocin ointment
Behavioral: Intensive education on personal hygiene
Genetic: Chlorhexidine showers
Procedure: Bleach baths (dilute)

First Posted Date: 2007-08-09

Last Posted Date: 2015-07-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 300

Registration Number: NCT00513799

Locations: 🇺🇸
Barnes-Jewish Hospital, St. Louis, Missouri, United States
🇺🇸
St. Louis Children's Hospital, St. Louis, Missouri, United States

AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia

Phase 1

Completed

Conditions: Leukemia, Myeloid, Acute

Interventions: Drug: AMD3100
Drug: Mitoxantrone
Drug: Etoposide
Drug: Cytarabine

First Posted Date: 2007-08-07

Last Posted Date: 2016-12-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 52

Registration Number: NCT00512252

Locations: 🇺🇸
Washington University, St. Louis, Missouri, United States

The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients

Phase 1

Completed

Conditions: Hyperphosphatemia

Interventions: Drug: Placebo
Drug: Niacinamide

First Posted Date: 2007-07-30

Last Posted Date: 2007-07-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 17

Registration Number: NCT00508885

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy